"Current biotechnological approaches for studying G protein coupled receptor structure, function and signaling".

نویسنده

  • Meng Cui
چکیده

Aims & Scope: G-protein -coupled receptors (GPCRs) are the largest class of cell-surface receptors and mediate most of our physiological responses to hormones, neurotransmitters, as well as being responsible for vision, olfaction and taste. They carry out a multitude of tasks in the central nervous system (CNS) and the periphery. Numerous diseases and disorders have been linked to mutations and polymorphisms in GPCRs, and they are the targets of an increasingly large number of therapeutic agents. Great progress has been made over the past three decades in understanding diverse GPCRs, from pharmacology to functional characterization in vivo. Recent high-resolution structural studies have provided insights into the molecular mechanisms of GPCR activation and constitutive activity. In this special issue of Current Pharmaceutical Biotechnology, we encourage our colleagues in the G protein coupled receptor (GPCR) field to submit review articles related to biotechnological approaches currently used in the field for studying GPCR structure, function, and signaling. The special interests include but are not limited to: 1. Using experimental approaches, such as, crystallography, Nuclear magnetic resonance (NMR), Cryo-electron microscopy (cryo-EM), etc. for GPCR structure determination. 2. Using computational approaches, such as, homology modeling, loop prediction, ab initio, for GPCR structure prediction. 3. Using experimental and computational approaches, such as, Cysteine cross-linking, FRET, single molecule photobleaching, protein docking, and Brownian or molecular dynamics simulations, etc. to study GPCR dimerization or oligomerization. 4. Using experimental and computational approaches, such as, radio labeling, NMR, molecular docking, etc. to study ligand-receptor interaction. 5. Using experimental approaches, such as, two-electrode voltage clamp (TEVC), cAMP cell-based assay, Epac assay, and calcium mobilization assay, etc. to characterize of GPCR signaling pathways. 6. Using computational approaches, such, molecular dynamics, adiabatic biased molecular dynamics, metadynamics, etc. to study GPCR activation and dynamics.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

G-protein Coupled Receptor Dimerization

A growing body of evidence suggests that GPCRs exist and function as dimers or higher oligomers. The evidence for GPCR dimerization comes from biochemical, biophysical and functional studies. In addition, researchers have shown the occurrence of heterodimerization between different members of the GPCR family. Two receptors can interact with each other to make a dimer through their extracellular...

متن کامل

Apelin: A promising therapeutic target? (Part 1)

Apelin is a recently discovered bioactive peptide, known to be an endogenous high-affinity ligandfor the previously orphan G protein-coupled receptor APJ. Apelin/APJ as a novel signaling pathwayhas been shown to play many crucial roles in cardiovascular function, blood pressure regulation, fluidhomeostasis, feeding behavior, obesity, type 2 diabetes mellitus, adipoinsular axis regulation, cellp...

متن کامل

Changes in regulator of G protein signaling-4 gene expression in the spinal cord of adrenalectomized rats in response to intrathecal morphine

Introduction: Regulators of G-protein signaling protein negatively control G protein -coupled receptor signaling duration by accelerating Gα subunit guanosine triphosphate hydrolysis. Since regulator of G-protein signaling4 has an important role in modulating morphine effects at the cellular level and the exact mechanism(s) of adrenalectomy-induced morphine sensitization have not been fully cl...

متن کامل

Dissecting G-Protein-Coupled Receptor Pharmacology

Drug discovery efforts targeting G-protein-coupled receptors (GPCR) have been immensely successful in creating new cardiovascular medicines. Currently marketed GPCR drugs are broadly classified as either agonists that activate receptors or antagonists that prevent receptor activation by endogenous stimuli. However, GPCR couple to a multitude of intracellular signaling pathways beyond classical ...

متن کامل

MINIREVIEW—EXPLORING THE BIOLOGY OF GPCRS: FROM IN VITRO TO IN VIVO Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism

The fact that over 30% of current pharmaceuticals target heptahelical G protein–coupled receptors (GPCRs) attests to their tractability as drug targets. Although GPCR drug development has traditionally focused on conventional agonists and antagonists, the growing appreciation that GPCRs mediate physiologically relevant effects via both G protein and non–G protein effectors has prompted the sear...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Current pharmaceutical biotechnology

دوره   شماره 

صفحات  -

تاریخ انتشار 2014